Authors: Glaspy, J Jadeja, JS Justice, G Kessler, J Richards, D Schwartzberg, L Rigas, J Kuter, D Harmon, D Prow, D Demetri, G Gordon, D Arseneau, J Saven, A Hynes, H Boccia, R O'Byrne, J Colowick, AB

Citation: J. Glaspy et al., A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy, BR J CANC, 84, 2001, pp. 17-23

Authors: Smith, RE Jaiyesimi, IA Meza, LA Tchekmedyian, N Chan, D Griffith, H Brosman, S Bukowski, R Murdock, M Rarick, M Saven, A Colowick, AB Fleishman, A Gayko, U Glaspy, J

Citation: Re. Smith et al., Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer, BR J CANC, 84, 2001, pp. 24-30

Authors: Colowick, AB Bohn, RL Avorn, J Ewenstein, BM

Citation: Ab. Colowick et al., Immune tolerance induction in hemophilia patients with inhibitors: costly can be cheaper, BLOOD, 96(5), 2000, pp. 1698-1702

Authors: Bohn, RL Colowick, AB Avorn, J

Citation: Rl. Bohn et al., Probabilities, costs, and outcomes: methodological issues in modelling haemophilia treatment, HAEMOPHILIA, 5(6), 1999, pp. 374-377